Aptevo Therapeutics Inc. Proceeds from Divestiture of Businesses
Aptevo Therapeutics Inc. (APVO) reported Proceeds from Divestiture of Businesses of $28.12 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2022-03-24
- Aptevo Therapeutics Inc. proceeds from divestiture of businesses for the quarter ending 2020-12-31 was $0.00.
- Aptevo Therapeutics Inc. proceeds from divestiture of businesses for the quarter ending 2020-09-30 was $0.00.
- Aptevo Therapeutics Inc. proceeds from divestiture of businesses for the quarter ending 2020-06-30 was $0.00.
- Aptevo Therapeutics Inc. proceeds from divestiture of businesses for the quarter ending 2020-03-31 was $28.12M.
- Aptevo Therapeutics Inc. proceeds from divestiture of businesses for fiscal 2020 was $28.12M, a 561.65% increase from fiscal 2019.
- Aptevo Therapeutics Inc. proceeds from divestiture of businesses for fiscal 2019 was $4.25M, a 6438.46% increase from fiscal 2018.
- Aptevo Therapeutics Inc. proceeds from divestiture of businesses for fiscal 2018 was $65.00K, a 99.89% decline from fiscal 2017.
- Aptevo Therapeutics Inc. proceeds from divestiture of businesses for fiscal 2017 was $59.76M.
| Period end | Proceeds from Divestiture of Businesses 0 month | Proceeds from Divestiture of Businesses | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $0.00 derived: sum of 2 quarters · filed 2022-03-24 | $0.00 derived: sum of 3 quarters · filed 2022-03-24 | $28.12M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $28.12M 10-Q · filed 2021-11-12 | $28.12M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $28.12M 10-Q · filed 2021-08-12 | $28.12M derived: sum of 3 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $28.12M 10-Q · filed 2021-05-11 | $28.12M derived: sum of 2 quarters · filed 2021-05-11 | ||||
| 2020-02-28 | $30.00M 10-Q · filed 2020-11-10 | $30.00M 10-K · filed 2021-03-31 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $4.25M 10-K · filed 2020-03-25 | ||||
| 2019-09-30 | $4.25M 10-Q · filed 2019-11-07 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $0.00 derived: sum of 2 quarters · filed 2020-03-25 | $11.00K derived: sum of 3 quarters · filed 2020-03-25 | $65.00K 10-K · filed 2020-03-25 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $11.00K derived: sum of 2 quarters · filed 2019-11-07 | $65.00K 10-Q · filed 2019-11-07 | -$649.00K derived: sum of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $65.00K 10-Q · filed 2019-08-09 | -$649.00K derived: sum of 3 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $54.00K 10-Q · filed 2019-05-09 | -$660.00K derived: sum of 2 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$714.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $59.76M 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | $60.48M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |